The new product reinforces Meridian’s leadership in enzyme stabilization and enables simplified and decentralized Next-Generation-Sequencing sample preparation. CINCINNATI–(BUSINESS WIRE)–The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS Enzymatic DNA Fragmentation Kit. The kit is designed … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate virtually in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference. Dr. Brady’s conversation … [Read more…]

BALLERUP, Denmark–(BUSINESS WIRE)–In 2025, LEO Pharma delivered a third consecutive year of double‑digit revenue growth (CER), at the upper end of guidance, and achieved a significant improvement in profitability, returning to positive net profit and free cash flow. The portfolio was strengthened by the launch of Anzupgo® in 10 additional markets, including the U.S., as … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–#Biotech–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one meetings at the following conference: Leerink Partners Global Healthcare Conference 2026 Dates: March 8–11, … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#darshanshah–Lindora, the leader in medical weight loss with a 55-year legacy, today announced the appointment of JJ Virgin as Chief Metabolic Health Officer, strengthening the brand’s commitment to innovation, measurable outcomes, and long-term metabolic health. In her new role, Virgin will spearhead the evolution of Lindora’s metabolic health programming, with a focus on … [Read more…]

Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends survival in preclinical models of HPV-related cancer EVANSTON, Ill.–(BUSINESS WIRE)–Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced a major, peer-reviewed publication demonstrating the power of its Spherical Nucleic Acid (SNA) platform in … [Read more…]

New FDA expansion of U.S. age indication extends EVO ICL use for patients 21 to 60 years old – making EVO ICL available to nearly 8 million additional refractive patients Lens-based vision correction with EVO ICL is now the leading procedure for U.S. patients with -8.0 diopters and above U.S. refractive market continues to shift … [Read more…]

Workers warn underfunding and unsafe staffing levels are putting children at risk TORONTO–(BUSINESS WIRE)–CUPE Local 2316, representing workers at the Children’s Aid Society of Toronto, are officially in a legal strike position as negotiations between the union and the employer have not led to an agreement and workers warn that a broader provincial funding crisis … [Read more…]

This collaboration brings medical and dental data together to better understand patient journeys and support more integrated care BOSTON–(BUSINESS WIRE)–CareQuest Institute for Oral Health®, a national nonprofit focused on creating a more accessible, equitable, and integrated oral health system, today announced a new partnership with Innovaccer, a leading health care AI company, to integrate medical … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced that the first participant has been dosed in a Phase 1 clinical study of JANX011, a CD19-targeted bispecific engineered using the company’s proprietary Adaptive Immune Response Modulator (ARM) platform. JANX011 is being developed for … [Read more…]